RadNet, Inc. (RDNT) vs Veracyte, Inc. (VCYT)
RadNet, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. RadNet, Inc. is the larger, with a market value of $5.6B against $3.9B — 1.4× the size. RadNet, Inc. has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 31.5×. RadNet, Inc. grew revenue faster over the last twelve months: 18.9% against 17.3%. Veracyte, Inc. has the higher net margin (20.4% vs −0.93%) and the higher return on invested capital (7.32% vs 2.24%). Across the 20 metrics below, Veracyte, Inc. leads on 16 and RadNet, Inc. on 4.
Valuation
Profitability
| Metric | RDNT | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 11.53% | 71.71% | 50.89% |
| Operating margin | 3.12% | 18.82% | (8.57%) |
| Net margin | (0.93%) | 20.37% | (6.37%) |
| Free cash flow margin | 3.28% | 29.54% | 0.00% |
| Return on equity | (1.64%) | 8.77% | (2.92%) |
| Return on assets | (0.55%) | 8.09% | (6.71%) |
| Return on invested capital | 2.24% | 7.32% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack